Total Payments
$28,322
2024 Payments
$16.78
Companies
43
Transactions
454
Medicare Patients
1,718
Medicare Billing
$113,536
Payment Breakdown by Category
Other$14,025 (49.5%)
Food & Beverage$7,848 (27.7%)
Consulting$5,160 (18.2%)
Travel$1,277 (4.5%)
Education$11.63 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,026 | 12 | 49.5% |
| Food and Beverage | $7,848 | 431 | 27.7% |
| Consulting Fee | $5,160 | 1 | 18.2% |
| Travel and Lodging | $1,277 | 8 | 4.5% |
| Education | $11.63 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mylan Specialty L.P. | $13,848 | 49 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $8,201 | 47 | $0 (2020) |
| GlaxoSmithKline, LLC. | $764.12 | 61 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $613.25 | 36 | $0 (2020) |
| Actelion Pharmaceuticals US, Inc. | $606.57 | 31 | $0 (2023) |
| Genentech USA, Inc. | $406.84 | 22 | $0 (2019) |
| United Therapeutics Corporation | $387.05 | 13 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $326.50 | 24 | $0 (2020) |
| Grifols USA, LLC | $309.59 | 15 | $0 (2020) |
| Shire North American Group Inc | $272.65 | 12 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.78 | 1 | Azurity Pharmaceuticals, Inc. ($16.78) |
| 2023 | $98.76 | 6 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($60.39) |
| 2022 | $87.17 | 5 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($43.97) |
| 2021 | $138.67 | 8 | Actelion Pharmaceuticals US, Inc. ($123.40) |
| 2020 | $16,663 | 73 | Mylan Specialty L.P. ($8,581) |
| 2019 | $7,390 | 155 | Mylan Specialty L.P. ($5,210) |
| 2018 | $2,179 | 109 | Boehringer Ingelheim Pharmaceuticals, Inc. ($486.88) |
| 2017 | $1,748 | 97 | United Therapeutics Corporation ($223.09) |
All Payment Transactions
454 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/15/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 08/29/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Gastroenterology | ||||||
| 07/05/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Gastroenterology | ||||||
| 06/05/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Cardiology | ||||||
| 05/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Gastroenterology | ||||||
| 05/10/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Cardiology | ||||||
| 02/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Gastroenterology | ||||||
| 11/23/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Gastroenterology | ||||||
| 10/07/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: Gastroenterology | ||||||
| 06/21/2022 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: Cardiology | ||||||
| 05/18/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Gastroenterology | ||||||
| 03/01/2022 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Cardiology | ||||||
| 08/10/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Cardiology | ||||||
| 07/06/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Cardiology | ||||||
| 05/11/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Cardiology | ||||||
| 04/15/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Cardiology | ||||||
| 03/02/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Cardiology | ||||||
| 02/24/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Cardiology | ||||||
| 01/27/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Cardiology | ||||||
| 01/21/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Respiratory | ||||||
| 12/04/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,075.00 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,075.00 | General |
| Category: RESPIRATORY | ||||||
| 11/16/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO ELLIPTA | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Education | In-kind items and services | $3.88 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2020 | Mylan Specialty L.P. | Yupelri (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,305.00 | General |
| Category: Respiratory and Allergy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 28 | 1,718 | 2,408 | $467,085 | $113,536 |
Total Patients
1,718
Total Services
2,408
Medicare Billing
$113,536
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 224 | 323 | $63,308 | $25,097 | 39.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 272 | 321 | $43,335 | $15,411 | 35.6% |
| 71250 | Ct scan chest | Office | 2020 | 108 | 128 | $115,200 | $8,770 | 7.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 69 | 69 | $20,424 | $8,019 | 39.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 49 | 49 | $16,619 | $7,759 | 46.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 48 | 55 | $14,300 | $6,171 | 43.2% |
| 94729 | Measurement of lung diffusing capacity | Office | 2020 | 148 | 151 | $43,035 | $6,054 | 14.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 38 | 63 | $12,600 | $4,968 | 39.4% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2020 | 109 | 109 | $22,672 | $4,273 | 18.8% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2020 | 82 | 82 | $15,990 | $3,581 | 22.4% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 34 | 35 | $21,175 | $3,575 | 16.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 27 | 52 | $7,540 | $2,909 | 38.6% |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | Office | 2020 | 16 | 16 | $5,232 | $2,848 | 54.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 19 | 19 | $6,384 | $2,572 | 40.3% |
| 94375 | Diagnostic testing in a pulmonary function lab | Office | 2020 | 78 | 79 | $11,060 | $2,233 | 20.2% |
| 86003 | Measurement of antibody (ige) to allergic substance | Office | 2020 | 13 | 416 | $9,984 | $2,141 | 21.4% |
| 82805 | Blood gases measurement | Office | 2020 | 23 | 25 | $3,350 | $1,887 | 56.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2020 | 64 | 70 | $14,000 | $1,733 | 12.4% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 42 | 47 | $4,277 | $740.40 | 17.3% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2020 | 32 | 45 | $1,575 | $675.90 | 42.9% |
| 36600 | Arterial puncture withdrawal of blood for diagnosis | Office | 2020 | 22 | 24 | $4,440 | $547.45 | 12.3% |
| 82375 | Carboxyhemoglobin (protein) level | Office | 2020 | 23 | 25 | $2,125 | $296.89 | 14.0% |
| 80069 | Kidney function blood test panel | Office | 2020 | 28 | 33 | $2,046 | $285.08 | 13.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 77 | 93 | $1,860 | $277.14 | 14.9% |
| 94762 | Overnight measurement of oxygen saturation in blood using ear or finger device | Office | 2020 | 13 | 15 | $1,575 | $259.55 | 16.5% |
About Dr. Scott Johnson, MD
Dr. Scott Johnson, MD is a Critical Care Medicine healthcare provider based in Pinehurst, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598739179.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Johnson, MD has received a total of $28,322 in payments from pharmaceutical and medical device companies, with $16.78 received in 2024. These payments were reported across 454 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($14,026).
As a Medicare-enrolled provider, Johnson has provided services to 1,718 Medicare beneficiaries, totaling 2,408 services with total Medicare billing of $113,536. Data is available for 1 year (2020–2020), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Pinehurst, NC
- Active Since 02/13/2006
- Last Updated 01/23/2017
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1598739179
Products in Payments
- Yupelri (Drug) $13,791
- OFEV (Drug) $7,723
- OPSUMIT (Drug) $489.11
- ORENITRAM (Drug) $387.05
- TRELEGY ELLIPTA (Drug) $311.63
- NUCALA (Biological) $307.14
- FASENRA (Drug) $282.42
- CUVITRU (Biological) $264.08
- LONHALA MAGNAIR (Drug) $220.18
- DUPIXENT (Biological) $196.21
- SYMBICORT (Drug) $181.94
- Prolastin-C Liquid (Biological) $174.55
- GIAPREZA (Drug) $138.47
- Prolastin-C (Biological) $135.04
- Esbriet (Biological) $131.18
- Adempas (Drug) $128.05
- XOLAIR (Biological) $118.87
- BEVESPI AEROSPHERE (Drug) $112.39
- ACTHAR (Biological) $112.20
- Xolair (Biological) $108.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Pinehurst
Mr. Daniel Feinstein, M.d, M.D
Critical Care Medicine — Payments: $278,151
Critical Care Medicine $278,151
Dr. Adam Belanger, M.d, M.D
Critical Care Medicine — Payments: $104,066
Critical Care Medicine $104,066
Jamie Warlick, Crna, CRNA
Critical Care Medicine — Payments: $329.03
Critical Care Medicine $329.03
Kristina Catania, M.d, M.D
Critical Care Medicine — Payments: $194.94
Critical Care Medicine $194.94
Ravi Jasti, Agacnp, AGACNP
Critical Care Medicine — Payments: $148.16
Critical Care Medicine $148.16
Alyssa Cummings, Crna, CRNA
Critical Care Medicine — Payments: $74.08
Critical Care Medicine $74.08